Literature DB >> 3055182

Non-O:1 Vibrio cholerae bacteremia: case report and review.

S Safrin1, J G Morris, M Adams, V Pons, R Jacobs, J E Conte.   

Abstract

A case of non-O:1 Vibrio cholerae bacteremia and prostatic abscess in a patient with idiopathic aplastic anemia was studied, and the data were compared with those from 23 previously reported cases of non-O:1 V. cholerae bacteremia. The case-fatality rate for the 13 cases for which the outcome is known is 61.5%. The majority of known cases have occurred in immunocompromised patients, particularly those with hematologic malignancy or cirrhosis. Host susceptibility is potentially important in this condition. Bacterial products such as a cholera-like toxin and El Tor hemolysin also may play a role in the disease process. The incidence of enteritis due to non-O:1 V. cholerae is unclear because of the methods used for routine stool culture; however, the small number of reported isolates from blood is likely to reflect the infrequency of bacteremia, since Vibrio species are readily identifiable on sheep blood agar. While non-O:1 V. cholerae is sensitive to most antibiotics in vitro, no data are available on antibiotic efficacy.

Entities:  

Mesh:

Year:  1988        PMID: 3055182     DOI: 10.1093/clinids/10.5.1012

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  33 in total

1.  Pro-inflammatory feedback activation cycle evoked by attack of Vibrio cholerae cytolysin on human neutrophil granulocytes.

Authors:  Angela Valeva; Ivan Walev; Silvia Weis; Fatima Boukhallouk; Trudy M Wassenaar; Sucharit Bhakdi
Journal:  Med Microbiol Immunol       Date:  2007-09-20       Impact factor: 3.402

2.  Spontaneous non-O1 Vibrio cholerae peritonitis after raw oyster ingestion in a patient with cirrhosis.

Authors:  C Rodríguez Ramos; P García Martos; F Galán Sánchez; M J Soria de la Cruz; L Martín Herrera
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

3.  Phenotypic and genotypic biotyping of environmental strains of Vibrio cholerae non-O1 isolated in Italy.

Authors:  E Filetici; L Bonadonna; M Ciccozzi; M P Anastasio; M Fantasia; T Shimada
Journal:  Appl Environ Microbiol       Date:  1997-10       Impact factor: 4.792

4.  Vibrio cholerae bacteremia associated with gastrectomy.

Authors:  A Toeg; S A Berger; A Battat; M Hoffman; I Yust
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

5.  Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.

Authors:  J G Morris; T Takeda; B D Tall; G A Losonsky; S K Bhattacharya; B D Forrest; B A Kay; M Nishibuchi
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences.

Authors:  J A Johnson; C A Salles; P Panigrahi; M J Albert; A C Wright; R J Johnson; J G Morris
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Occurrence of Vibrio cholerae serogroups other than O1 and O139 in Austria.

Authors:  Steliana Huhulescu; Alexander Indra; Gebhard Feierl; Anna Stoeger; Werner Ruppitsch; Banwarial Sarkar; Franz Allerberger
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

8.  Quadruplex real-time PCR assay for detection and identification of Vibrio cholerae O1 and O139 strains and determination of their toxigenic potential.

Authors:  Jianwei Huang; Yumei Zhu; Huixin Wen; Jiafeng Zhang; Shijie Huang; Jianjun Niu; Qingge Li
Journal:  Appl Environ Microbiol       Date:  2009-09-18       Impact factor: 4.792

9.  Vibrio-associated gastroenteritis in the lower Cross-River Basin of Nigeria.

Authors:  J A Ndon; S M Udo; W B Wehrenberg
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

10.  Massive fluid requirements and an unusual BUN/creatinine ratio for pre-renal failure in patients with cholera.

Authors:  Muhammad Tariq; Murtaza Memon; Asif Jafferani; Sana Shoukat; Saqib Ali Gowani; Rabeeya Nusrat; Mehmood Riaz; Junaid Patel; Bushra Jamil; Raymond A Smego
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.